Prediction by Low Plasma HbA(1c) of Mortality, Cardiac and Noncardiac Disease Risk: Modulation by Diabetic Status and Sex


Altay S., Onat A., KARADENIZ Y., OZPAMUK-KARADENIZ F., Can G.

JOURNAL OF INVESTIGATIVE MEDICINE, cilt.63, sa.6, ss.821-827, 2015 (SCI-Expanded, Scopus) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 63 Sayı: 6
  • Basım Tarihi: 2015
  • Doi Numarası: 10.1097/jim.0000000000000216
  • Dergi Adı: JOURNAL OF INVESTIGATIVE MEDICINE
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.821-827
  • Anahtar Kelimeler: type 2 diabetes, chronic kidney disease, coronary heart disease, glycated hemoglobin, ALL-CAUSE MORTALITY, GLYCATED HEMOGLOBIN, SERUM CREATININE, GLYCEMIC CONTROL, CARDIOVASCULAR OUTCOMES, AUTOIMMUNE ACTIVATION, NONDIABETIC ADULTS, METABOLIC SYNDROME, HEART-FAILURE, CANCER
  • İstanbul Üniversitesi-Cerrahpaşa Adresli: Hayır

Özet

Aim The aim of the study was to evaluate the predictive value of HbA(1c) for risk of overall mortality or a composite endpoint of death and nonfatal events.